INTRODUCTION
============

Peroxidasins are extracellular enzymes that contain a peroxidase domain and motifs of extracellular matrix (ECM) proteins, leucine-rich repeats (LRRs), and immunoglobulin (Ig) domains. The peroxidasins' putative functions in host defense via antibacterial activity and in ECM formation have already been suggested and reviewed ([@b11-molcell-38-1-51]; [@b16-molcell-38-1-51]). Recent studies in the role that peroxidasins may play in tissue biogenesis have generated clinical and therapeutic interest as well ([@b12-molcell-38-1-51]). Despite their abundance among species, there have been few studies aimed at revealing peroxidasin's roles, especially *in vivo* ([@b11-molcell-38-1-51]; [@b16-molcell-38-1-51]).

There are two peroxidasin homologues, PXN-1 and PXN-2, in *Caenorhabditis elegans* (*C. elegans*), and in-depth research has revealed an important role for PXN-2 in embryonic morphogenesis, in muscle-epidermal attachment, and in adult axon regrowth following injury in worms ([@b5-molcell-38-1-51]). Moreover, the peroxidase activity of PXN-2 has been shown to be critical for its function. A recent study has further shown that peroxidasins catalyze sulfilimine (S=N) bond formation between a methionine sulfur and a hydroxylysine nitrogen to strengthen the collagen IV network in the ECM ([@b1-molcell-38-1-51]; [@b4-molcell-38-1-51]; [@b6-molcell-38-1-51]; [@b21-molcell-38-1-51]). Therefore, peroxidasins in *C. elegans* are able to catalyze sulfilimine bond formation to strengthen epidermal-muscle attachments, and/or muscle-muscle attachments ([@b1-molcell-38-1-51]).

To date, no specific roles in development have been ascribed to the *pxn-1* gene and no function has been assigned to PXN-1 in *C. elegans*. It is thought that *pxn-1* and *pxn-2* may have an antagonistic functional relationship in *C. elegans* ([@b5-molcell-38-1-51]), although conclusive evidence has not been presented yet. Furthermore, it is worth investigating the roles of *C. elegans* peroxidasins in detail, especially through characterization of *pxn-1* mutants under stress conditions. Such conditions may be necessary to reveal a mutant phenotype not seen under normal conditions. Here we present an in-depth study on the role of *pxn-1* in *C. elegans* through mutant and transgenic analysis in varying environmental conditions. Our results suggest that PXN-1 may have a role in the attachment of tissues and in neuronal guidance during development.

MATERIALS AND METHODS
=====================

Strains and culture conditions
------------------------------

The wild-type Bristol N2 strain, *pxn-1*(*ok785*) deletion mutant, and *juIs76*(*Punc-25::GFP*) ([@b7-molcell-38-1-51]) were obtained from the *Caenorhabditis elegans* Genetics Center (CGC) at the University of Minnesota. Breeding of *C. elegans* was carried out according to published protocols ([@b2-molcell-38-1-51]).

Survival assay and heat stress
------------------------------

For synchronization, gravid worms were treated with hypochlorite and then washed with M9 buffer several times. The eggs were used for the experiments. To measure survival rates, approximately 500 individual eggs of wild-type and *pxn-1 (ok785)* worms were grown to young adults at 20°C or 25°C (mild heat stress), and subsequently the live worms were counted. For severe 30°C heat stress (HS) experiments, wild-type and *pxn-1*(*ok785*) worms were incubated at 20°C as the baseline condition and were then subjected to heat stress at 30°C for 1 h every 12 h.

Constructs and transformation
-----------------------------

To prepare the transcriptional fusion constructs, approximately 3 kb of the 5′-upstream region of *pxn-1* and 2.2 kb of *pxn-2* were amplified by polymerase chain reaction and then inserted into a promoterless green fluorescent protein (GFP) vector pPD95.77, yielding *Ppxn-1:: GFP* and *Ppxn-2:: GFP*.

To prepare the translational fusion constructs, *pxn-1* and *pxn-2* genomic DNA were ligated to *pxn-1* and *pxn-2* promoters with GFP and mCherry to yield *Ppxn-1::pxn-1::GFP* and *Ppxn-2::pxn-2::mCherry*, respectively. For the quantification of axon abnormalities, *Ppxn-1::pxn-2::mCherry* and *Ppxn-2::pxn-1::GFP* were constructed as well. The heat shock promoter from Fire vector (pPD49.83) was fused with the *pxn-1* and *pxn-2* translational constructs, *Phs::pxn-1::GFP* and *Phs::pxn-2::mCherry*.

Microinjection was carried out as previously described ([@b9-molcell-38-1-51]). As a transformation marker, the plasmid pRF4 containing a dominant gene (*rol-6*) was co-injected with the translational fusion constructs into *juIs76*(*Punc*-*25*::*GFP*). Transgenic worms were thereafter isolated by their rolling pattern and GFP expression was detected using a fluorescent microscope system (80i-DS-Fi1, Nikon).

Assessing neuronal development
------------------------------

The transgenic animals (at least 300 individuals per treatment) were cultured as described above. Worms overexpressing peroxidasins in response to heat shock (*Phs::pxn-1*::*GFP* and *Phs::pxn-2*::*mCherry*) were subjected to heat shock at 30°C for 1.5 h every 12 h. An individual worm that displayed at least one defect when observed under the microscope was scored as a neuronal defect. A defective neuron was defined as a neuron showing incorrect handedness, breakage, tangling, branching, or defasciculation.

To assess neuronal development in *pxn-1* overexpressing strains (*Phs::pxn-1*::*GFP*) at different developmental stages, synchronized embryos, larvae, and adults were heat shocked once at 30°C for 1.5 h at different developmental stages. When they reached the young adult stage, the neuronal defects were scored. When the treatment was to be applied at the adult stage, worms were exposed to heat shock once they had reached the adult stage and their neuronal defects were counted one day later.

RESULTS AND DISCUSSION
======================

Phenotypic analysis of *C. elegans pxn-1* mutants
-------------------------------------------------

Recently, Gotenstein et al. genetically characterized two *C. elegans* peroxidasins, *pxn-1* and *pxn-2*. In that study, various *pxn-2* mutants were investigated in detail by characterizing eight mutants. These mutants had defects in epidermal elongation, muscle-epidermal attachment, and/or muscle-muscle attachment during development ([@b5-molcell-38-1-51]). Although sequence alignment studies revealed a high homology between PXN-1 and PXN-2 proteins (52% identity and 69% similarity, data not shown), their phenotypes were different, with *pxn-2* mutants displaying obvious and severe defects and *pxn-1* mutants displaying no obvious phenotypes ([@b5-molcell-38-1-51]). Such differences between the mutants suggest different roles for the two peroxidasins. Upon examination of the *pxn-1* deletion mutant (*ok785*) for general characteristics such as growth rate (from egg to adult) and brood size, we found some differences between the *pxn-1* mutant and wild-type *C. elegans*. At 20°C, the *pxn-1* mutant showed growth retardation compared to wild-type (N2), 70 h and 64 h at 20°C respectively. The brood size of the *pxn-1* mutant was slightly smaller in comparison to wild-type, the two strains averaging 256 and 298, respectively. *pxn-1* showed no obvious morphological defects under normal conditions, which is in agreement with the results from previous work ([@b5-molcell-38-1-51]). However, when we varied conditions, we found some profound changes in the *pxn-1* mutant. We examined *pxn-1* phenotypes under stress conditions such as oxidative and heat stress. Treatment with the chemical paraquat, which can induce oxidative stress, did not cause any changes compared to wild-type (data not shown). However, high temperature dramatically increased lethality in the *pxn-1* mutant. Wild-type and the *pxn-1* mutant were grown at 20°C or 25°C (mild heat stress) from egg to adult. Worms grown under severe heat stress conditions were exposed to 30°C only for 1 h every 12 h from egg to adult because harsh temperatures normally cause death in *C. elegans*. Wild-type worms showed little difference in their survival rates, either at 25°C (90%) or at 30°C (89%) compared to survival at 20°C (98%) ([Fig. 1A](#f1-molcell-38-1-51){ref-type="fig"}). The mutant was more susceptible to heat stress-mediated lethality, however, exhibiting 58% survival at 25°C and 53% at 30°C but 93% survival at 20°C.

We also observed that heat stress conditions caused the formation of large vacuoles in the *pxn-1* mutant, particularly between the pharynx and the epidermis in the anterior region (arrows in [Figs. 1B](#f1-molcell-38-1-51){ref-type="fig"} and [1C](#f1-molcell-38-1-51){ref-type="fig"}) and between the gonad and the epidermis in the mid-body section (arrows in [Fig. 1D](#f1-molcell-38-1-51){ref-type="fig"}). We observed this phenotype in 23.5% of *pxn-1* mutant animals and in only 5.5% of the wild-type animals. Moreover, since the *pxn-1* mutants had high lethality, and since we were only able to observe the surviving young adults, the prevalence of vacuole formation may actually be higher than the 23.5% we observed.

According to [@b5-molcell-38-1-51] *pxn-2* adults showed a similar vacuole phenotype around the pharyngeal region under normal conditions. These vacuoles may be the result of weak attachments and/or cell necrosis between tissues due to breaching of the ECM. As the worm moves along using its body muscles, detachment of tissue becomes even more magnified. We conjectured that increased temperature had induced hyperactive movement in the worms, thereby magnifying detachment and/or necrosis phenotypes. To test whether this may also be the case for *pxn-1* mutants, we paralyzed the worms by treatment with levamisole, an agonist of the acetylcholine receptor. However, neither wild-type nor *pxn-1* animals had any apparent improvement in their survival rates or vacuole phenotypes upon levamisole treatment.

Since one of peroxidasin's proposed roles is in host defense via antibacterial activity, we tested whether the increased lethality is due to infection by *E. coli*. The OP50 strain of *E. coli* is normally used in the laboratory as food for bacteriovorous *C. elegans*; however, under some conditions OP50 can be toxic to the worms. We fed UV-killed OP50 to *pxn-1* to test whether the increased lethality in *pxn-1* results from weak host defense. No difference in survival rates was found between live and UV-killed bacteria feeding (data not shown). Our experiments here indicate that neither excessive movement nor bacterial infection is the direct cause of the observed lethality under stress conditions.

On the other hand, several studies demonstrate that disturbances in ECM structure can result in morphological and development phenotypes in *C. elegans* ([@b14-molcell-38-1-51]; [@b18-molcell-38-1-51]; [@b19-molcell-38-1-51]; [@b20-molcell-38-1-51]). From observations and available reports, a correlation can be drawn between the vacuole phenotypes and increased lethality, which indicates important roles of *pxn-1* in ECM structural integrity and function under heat stress conditions.

*pxn-1* is expressed throughout developmental stages and in various tissues
---------------------------------------------------------------------------

To better understand the roles of *pxn-1* in *C. elegans*, the *pxn-1* gene expression pattern was observed using *pxn-1* transcriptional GFP reporters (*Ppxn-1::GFP*) injected into either wild-type or *pxn-1* mutants. Wild-type transgenic animals showed a constant expression of *pxn-1* throughout their development, starting from the egg and continuing through to the adult stages ([Figs. 2A--2C](#f2-molcell-38-1-51){ref-type="fig"}). The expression patterns were associated with the ventral nerve cord (VNC), the dorsal nerve cord (DNC), body wall muscles (open arrow, arrow, and arrowhead, respectively, in [Fig. 2C](#f2-molcell-38-1-51){ref-type="fig"}), neurons, vulval muscles, uterine muscles, head neurons, intestine, and hypodermis ([Figs. 2D--2H](#f2-molcell-38-1-51){ref-type="fig"}, respectively). These expression patterns were consistent with the *Ppxn-1-GFP* expression pattern seen in a previous study ([@b5-molcell-38-1-51]). In D, lateral cholinergic neurons are visualized---ALN and PLN (arrow and open arrow)---as well as GABAergic neurons, including commissures (COs, arrowheads). Moreover, the patterns were observed in excretory cells and in the spermathecal-uterine valve (data not shown). An arrow and an arrowhead in [Fig. 2F](#f2-molcell-38-1-51){ref-type="fig"} indicate the nerve ring and a pharyngeal neuron, respectively. In the *pxn-1* mutant, pharyngeal neurons displayed increased GFP expression levels (arrowhead, [Fig. 2I](#f2-molcell-38-1-51){ref-type="fig"}). In addition, the pharyngeal muscle (pm3) became visible in the *pxn-1* mutant (open arrowhead, [Fig. 2I](#f2-molcell-38-1-51){ref-type="fig"}). These enhanced GFP expressions in mutant animals may result from upregulation of *pxn-1* gene expression due to a lack of functional PXN-1 proteins. They could also indicate reciprocal regulation of *pxn-1* by *pxn-2* in light of the proposed antagonistic relationship between these two proteins ([@b5-molcell-38-1-51]).

PXN-1::GFP is localized in extracellular matrix (ECM)
-----------------------------------------------------

The previous study by [@b5-molcell-38-1-51] showed that PXN-2 is localized to the epidermis and plays an important role in muscle-epidermal attachment. We also observed possible attachment defects in *pxn-1* mutants under heat stress conditions, indicating a need for careful examination of PXN-1 protein localization. We constructed a GFP-tagged transgene containing the *pxn-1* promoter and *pxn-1* gene (*Ppxn-1::pxn-1::GFP*) or an mCherry-tagged *pxn-2* promoter and the *pxn-2* gene (*Ppxn-2::pxn-2::mCherry*). These constructs were co-injected into wild-type animals. PXN-1::GFP expressed all along the body of the animal ([Fig. 3A](#f3-molcell-38-1-51){ref-type="fig"}), but the expression was more distinctly found in the muscle-muscle attachment regions (arrows in [Figs. 3C](#f3-molcell-38-1-51){ref-type="fig"} and [3D](#f3-molcell-38-1-51){ref-type="fig"}; D, DIC image of C). Conversely, PXN-2::mCherry expressed in regions somewhat different from those that were found to express PXN-1 ([Fig. 3B](#f3-molcell-38-1-51){ref-type="fig"}). Specifically, PXN-1::GFP expression localized between body wall muscle cells (arrows in [Fig. 3E](#f3-molcell-38-1-51){ref-type="fig"}), but such expression was not observed for PXN-2::mCherry ([Fig. 3F](#f3-molcell-38-1-51){ref-type="fig"}, the same image of E). PXN-1 and PXN-2 were localized in the coelomocytes (arrowheads in [Figs. 3E](#f3-molcell-38-1-51){ref-type="fig"} and [3F](#f3-molcell-38-1-51){ref-type="fig"}) and PXN-2 was found in the hypodermis ([Figs. 3F](#f3-molcell-38-1-51){ref-type="fig"} and [3H](#f3-molcell-38-1-51){ref-type="fig"}). Interestingly, PXN-1::GFP was distributed along the pharynx ([Fig. 3G](#f3-molcell-38-1-51){ref-type="fig"}), which signifies that PXN-1 may function in the attachments between pharynx and hypodermis. The localization of PXN-1 is consistent with the location of the vacuoles shown in [Fig. 1C](#f1-molcell-38-1-51){ref-type="fig"} (arrows) along the pharynx. In addition, since PXN-1 and PXN-2 were both localized to the coelomocytes, it appears that both are likely secretory proteins ([Figs. 3E](#f3-molcell-38-1-51){ref-type="fig"} and [3F](#f3-molcell-38-1-51){ref-type="fig"}).

PXN-1 is involved in neuronal development
-----------------------------------------

We showed that *pxn-1* is prominently expressed in neurons, including GABAergic and cholinergic neurons. We therefore asked whether *pxn-1* has any roles in neuronal development. We used the *pxn-1* promoter region (*Ppxn-1::GFP*) in wild-type, *pxn-1* mutants, and *pxn-1* over-expressing worms. In the wild-type transgenic animals, commissures (CO) at the anterior end of the body connect from the ventral nerve cord (VNC) to the dorsal nerve cord (DNC) and vice versa. In the same way, COs on the left side of the body (DD1 and VD2, arrowheads in [Figs. 4A--4C](#f4-molcell-38-1-51){ref-type="fig"}) are connected in a similar manner to the right side of the body (VD3 to VD13 and DD2 to DD6, arrows in [Fig. 4B](#f4-molcell-38-1-51){ref-type="fig"}). On the other hand, *pxn-1* mutants displayed wrong-sided handedness of the COs (see many arrows in [Fig. 4C](#f4-molcell-38-1-51){ref-type="fig"}). Moreover, *pxn-1* overexpressing animals (*Ppxn-1::pxn-1::GFP*) showed a similar pattern, with many COs located on the wrong side ([Fig. 4D](#f4-molcell-38-1-51){ref-type="fig"}). Some of them also showed over-branching at the ends of neurons (arrowheads in [Fig. 4D](#f4-molcell-38-1-51){ref-type="fig"}, inset). High-magnification images illustrated prominent breakages in ALN (a cholinergic sensory neuron) in the *pxn-1* mutant (arrows in [Fig. 4F](#f4-molcell-38-1-51){ref-type="fig"}). Furthermore, the abnormal patterns of COs, for instance, tangled neurons (arrowheads in [Fig. 4G](#f4-molcell-38-1-51){ref-type="fig"}), misguided neurons (arrows in [Figs. 4G](#f4-molcell-38-1-51){ref-type="fig"} and [4H](#f4-molcell-38-1-51){ref-type="fig"}), and disconnected neurons (open arrow in [Fig. 4H](#f4-molcell-38-1-51){ref-type="fig"}) observed in overexpressing animals (*Ppxn-1::pxn-1*, [Figs. 4G](#f4-molcell-38-1-51){ref-type="fig"} and [4H](#f4-molcell-38-1-51){ref-type="fig"}) were rarely observed in wild-type animals ([Fig. 4E](#f4-molcell-38-1-51){ref-type="fig"}). To confirm the role of PXN-1 in neuronal development, we ectopically expressed *pxn-1* using a heat shock promoter (*Phs::pxn-1::GFP*). Expression of this construct alone without heat shock showed no differences compared to wild-type. However, upon heat shock, defects in neuronal navigation were clearly apparent ([Figs. 4J](#f4-molcell-38-1-51){ref-type="fig"} and [4K](#f4-molcell-38-1-51){ref-type="fig"}). In animals ectopically expressing *pxn-1* by heat shock, the COs not only displayed loss of direction but were also shown to tangle with each other (arrowheads in [Figs. 4J](#f4-molcell-38-1-51){ref-type="fig"} and [4K](#f4-molcell-38-1-51){ref-type="fig"}). Abnormal arrangements such as defasciculated neurons were also found in the *pxn-1* mutant (arrow in [Fig. 4I](#f4-molcell-38-1-51){ref-type="fig"}) as well as in the animals ectopically expressing *pxn-1* (arrow in [Fig. 4J](#f4-molcell-38-1-51){ref-type="fig"}). Because *juIs76(Punc-25:: GFP)* is expressed specifically in GABAergic neurons ([@b7-molcell-38-1-51]), we also used *juIs76* to confirm the neuronal developmental defects in the *pxn-1* mutant and in over-expressing animals. Using the *Punc-25::GFP* we were able to confirm all the neuronal defects we observed using *Ppxn-1::GFP* in the *pxn-1* mutant and in over-expressing animals.

The abnormal neuronal development defects---meandering, breakage, branching, and defasciculated COs---have previously been observed in mutants characterized by unstable ECM structure ([@b8-molcell-38-1-51]; [@b15-molcell-38-1-51]). This is in agreement with the fact that axonal guidance is dependent upon various cues such as signaling molecules or structural molecules situated in the ECM ([@b3-molcell-38-1-51]; [@b10-molcell-38-1-51]; [@b17-molcell-38-1-51]). Hence, from these qualitative observations and existing reports, we think that PXN-1 plays important roles in neuronal development via an influence on ECM integrity.

We further quantified the neuronal development abnormalities using the *juIs76(Punc-25::GFP)* strain. When compared with wild-type (*juIs76*), the corresponding *pxn-1* mutant (*pxn-1 juIs76*) demonstrated increased neuronal defects (32% and 48.7% of animals affected, respectively, [Fig. 5A](#f5-molcell-38-1-51){ref-type="fig"}). Moreover, *pxn-1* overexpressing animals under the control of a *pxn-1* promoter (*Ppxn-1::pxn-1::GFP*) showed a drastic increase in axonal abnormalities to about 72.3%. We also swapped promoters and overexpressed either *pxn-1* with a *pxn-2* promoter (*Ppxn-2::pxn-1::GFP*) or *pxn-2* with a *pxn-1* promoter (*Ppxn-1::pxn-2::mCherry*). Neither of these showed much difference from wild-type. These results indicate that peroxidasin's expression under the proper promoter and in the proper location is critical for its function.

Acute overexpression of *pxn-1* using a heat-shock promoter *(Phs::pxn-1::GFP)* was also effective in increasing the prevalence of aberrations, by about 69% ([Fig. 5B](#f5-molcell-38-1-51){ref-type="fig"}). Thus, increased neuronal defects in *pxn-1* mutant and *pxn-1* overexpressing animals (*cis*- or ectopic) indicate that PXN-1 plays an important role in neuronal development. We also expressed *pxn-*2 under*:* the control of various promoters (*Ppxn-1::pxn-2::mCherry, Ppxn-2::pxn-2::mCherry* and *Phs:pxn-2::mCherry*). As mentioned previously, there were no apparent effects in *Ppxn-1::pxn-2::mCherry* neurons. However, *pxn-2* overexpressing animals (either *cis*- or ectopic) had increased axonal defects. This suggests some relationship between PXN-1 and PXN-2 consistent with what has been previously proposed ([@b5-molcell-38-1-51]).

In addition, we asked whether PXN-1's role in neuronal development is specific to a critical period in development, or whether it plays a general role. Accordingly, we used transgenic worms that expressed *pxn-1* under a heat shock promoter (*Phs::pxn-1::GFP*) and applied heat shock at different developmental stages to assess the role of PXN-1 throughout development. Neuronal defects of *pxn-1* ectopic expression were much more prominent at early developmental stages, i.e., from embryo to larval stages ([Fig. 5C](#f5-molcell-38-1-51){ref-type="fig"}), which indicates that *pxn-1* plays critical roles in neuronal development at early developmental stages. Moreover, we observed that *pxn-1* was expressed constantly throughout the adult worm's lifetime, (data not shown), which could indicate involvement in neuronal maintenance during the aging process. Thus, the role of PXN-1 in neuronal development is acute and may be stage-specific during development and throughout the lifetime of the worm.

Our previous analysis of the *pxn-1* mutant indicated that it was sensitive to heat stress. Thus, we also scored neuronal defects in the *pxn-1* mutant animals that survived at 25°C ([Fig. 5D](#f5-molcell-38-1-51){ref-type="fig"}). Moreover, even in wild-type worms heat stress alone induced neuronal developmental defects ([Fig 5D](#f5-molcell-38-1-51){ref-type="fig"}). In the *pxn-1* mutant, heat stress did not cause any synergistic increases in neuronal defects compared to wild-type at 25°C ([Fig 5D](#f5-molcell-38-1-51){ref-type="fig"}) or at 30°C (data not shown). However, once again, heat stress led to high lethality in the *pxn-1* mutant such that the prevalence of neuronal defects may actually have been much higher than our results indicate.

Our results further indicate that *pxn-1* function is different from that of *pxn-2*, at least in the context of neuronal navigation. These results are consistent with the rescue experiments reported earlier, wherein a peroxidase domain of *pxn-1* was unable to rescue *pxn-*2 mutant phenotypes ([@b5-molcell-38-1-51]). An inability to rescue *pxn-2* mutant phenotypes may be a consequence of antagonistic roles for *pxn-1* and *pxn-2*, or of a differentiation of their roles temporally and/or spatially. A recent study on peroxidasins and peroxidasin-like proteins showed that human vascular peroxidasins are expressed in heart, and are putatively down-regulated by peroxidasin-like proteins ([@b13-molcell-38-1-51]). The peroxidasin-like protein consists of a peroxidase domain lacking the crucial enzyme activity and cell adhesion domains, such as leucine-rich repeats (LRRs) and immunoglobulin (Ig) domains. Hence, it is suggested that peroxidasin and peroxidasin-like protein can form complexes to inhibit the peroxidase activity of peroxidasin for proper regulation ([@b13-molcell-38-1-51]). The relationship between *pxn-1* and *pxn-2* in *C. elegans* may be similar to this interaction between peroxidasin and peroxidasin-like protein in the human heart. Further investigation of the relationship between *pxn-1* and *pxn-2* in neuronal development and maintenance and in attachments between tissues should prove rewarding.
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![Defective phenotypes of *pxn-1* mutants under heat stress conditions. Wild-type (WT) and *pxn-1*(*ok785*) mutant were exposed constantly to normal or higher temperature at 20°C or 25°C, respectively, except for heat stress at 30°C. Heat treatment at 30°C was continued for 1 h in every 12 h throughout development from embryo to young adults. All young adults survived at 20°C, 25°C and 30°C were counted; mean ± S.D. n = 500 individuals per each line (A). The severe phenotypes of *pxn-1* mutant larvae under heat stress condition at 25°C are represented in head (B, C) and mid-body (D). Arrows represent vacuoles. Scale bar, 50 μm.](molcell-38-1-51f1){#f1-molcell-38-1-51}

![Expression of *pxn-1*. *Ppxn-1::GFP* transcriptional fusion constructs were injected into wild-type and *pxn-1* mutants. In wild-type worms, *pxn-1* expressed throughout development, from an embryo through adult stages \[(A), embryo; (B), Larva L3; and C, adult; arrowhead, body wall muscle; open arrow, ventral nerve cord (VNC); solid arrow, dorsal nerve cord (DNC) in (C)\] and in various tissues \[(D), neurons; (E), vulva and uterine muscles; (F), head neurons; (G), intestine and (H), hypodermis\]. In (D), ALN, PLN, and GABAergic neurons were represented as an arrow, an open arrow and arrowheads respectively. In (F) and (I), arrows represent nerve ring and solid arrowheads pharyngeal neurons. In *pxn-1* mutants (I), the expression was observed in head neurons and pharyngeal muscles \[pm3, open arrowhead in (I)\]. Scale bars, 50 μm in (A--C), and (D--I).](molcell-38-1-51f2){#f2-molcell-38-1-51}

![Localization of PXN-1 and PXN-2. *Ppxn-1::pxn-1::GFP* and *Ppxn-2::pxn-2::mCherry* translational fusion constructs were co-injected into wild-type. PXN-1 localization is represented by the GFP expressions \[(A), (C), (E), and (G)\], and PXN-2 localization is represented by mCherry \[(B), (F), and (H)\]. GFP expressions were intense in muscle-muscle attachment regions \[arrows in (C), (D), and (E)\]. The same image of (C) was represented as a DIC image in (D). Arrowheads in (E) and (F) represent coelomocytes. PXN-1 is localized along with pharynx \[arrowhead in (G)\], and PXN-2 in hypodermis (H). Scale bar, 50 μm in (A, B) and (C--H).](molcell-38-1-51f3){#f3-molcell-38-1-51}

![Defects of axonal navigation in *pxn-1* mutants and overexpressing animals. In wild-type transgenic animals, ALN, cholinergic neuron (arrow) and DD1 and VD2 neuron \[arrow head, the same applied to (B, C)\] were located on the left side (A) and arrows represented GABAergic neurons (VD3-VD13 and DD2 - DD6) on the right side (B). In *pxn-1* mutant and overexpressing worms (*Ppxn-1::pxn-1::GFP*), motor neurons \[arrows in (C, D) respectively\] were extended on the wrong side, the left. Inset of (D) was the enlarged image of the dotted box and the arrowheads showed over-branching of nerve ends. Representative neuron images of wild-type (E), *pxn-1* mutant (F, I), *Ppxn-1::pxn-1::GFP* (G, H), and *Phs::pxn-1::GFP* (J, K): axonal breakage \[arrows in (F) and open arrow in (H)\], prematurely branching \[arrows in (G) and (H)\], tangling \[arrowheads in (G, J, and K)\], defasciculation \[arrows in (I, J)\]. Scale bars, 50 μm in A--D and E--K.](molcell-38-1-51f4){#f4-molcell-38-1-51}

![The degree of incidence of neuronal defects in various transgenic animals, different developmental stages, and heat stress condition. Abnormal axonal occurrences in wild-type, *pxn-1* mutants, *Ppxn1::pxn-1*, *Ppxn-1::pxn-2::mCherry*, *Ppxn-2::pxn-1*, and *Ppxn-2::pxn-2::mCherry* were represented as percentage (A). Neuronal defects in ectopic *pxn-1::GFP* and *pxn-2::mCherry* over-expression (*Phs:: pxn-1::GFP* and *Phs::pxn-2::mCherry*) were represented as percentage (B). The percentage of abnormal neurons in *pxn-1* ectopic expression (*Phs::pxn-1::GFP*) at different developmental stages were represented; egg, L1-L2, L3-L4, and adult (C). Temperature effects on axon abnormality in wild-type and *pxn-1* mutants (D). All experiments were performed in the *juIs76*(*Punc-25::GFP*) line. N \> 300 individuals per each line. Error bar = STD. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001; Student's *t*-test.](molcell-38-1-51f5){#f5-molcell-38-1-51}
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